Targeting Mutant KRAS and Its Metabolic Dependencies in Pancreatic Cancer Using Lipid Nanoparticle Delivery Systems

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:864 / 864
页数:1
相关论文
共 50 条
  • [1] Lipid Nanoparticle Mediated Co-targeting of Genetic and Metabolic Dependencies in Pancreatic Cancer
    Jyotsana, N.
    Koktysh, D.
    Ta, K.
    DelGiorno, K.
    PANCREAS, 2021, 50 (07) : 1069 - 1069
  • [2] Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
    Encarnacion-Rosado, Joel
    Sohn, Albert S. W.
    Biancur, Douglas E.
    Lin, Elaine Y.
    Osorio-Vasquez, Victoria
    Rodrick, Tori
    Gonzalez-Baerga, Diana
    Zhao, Ende
    Yokoyama, Yumi
    Simeone, Diane M.
    Jones, Drew R.
    Parker, Seth J.
    Wild, Robert
    Kimmelman, Alec C.
    NATURE CANCER, 2024, 5 (01) : 85 - 99
  • [3] Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
    Joel Encarnación-Rosado
    Albert S. W. Sohn
    Douglas E. Biancur
    Elaine Y. Lin
    Victoria Osorio-Vasquez
    Tori Rodrick
    Diana González-Baerga
    Ende Zhao
    Yumi Yokoyama
    Diane M. Simeone
    Drew R. Jones
    Seth J. Parker
    Robert Wild
    Alec C. Kimmelman
    Nature Cancer, 2024, 5 : 85 - 99
  • [4] Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
    Encarnacion-Rosado, Joel
    Kimmelman, Alec C.
    Wild, Robert
    CANCER RESEARCH, 2024, 84 (02)
  • [5] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Targeting lipid metabolism disrupts KRAS oncogenesis in pancreatic cancer
    Arora, Neha
    Liang, Hong
    Reed, Alex
    Chang, Jeffrey T.
    Cravatt, Benjamin F.
    Zhou, Yong
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Targeting KRAS selectively induce metabolic reprogramming in pancreatic cancer
    Shiekh, Laiba
    Cheung, Matthew
    Zheng, Linyuhui
    Marlette, Erica
    Ezeh, Chiamaka J.
    Conde, Don-Gerard
    Nwosu, Zeribe C.
    CANCER RESEARCH, 2024, 84 (17)
  • [8] Targeting KRAS-regulated metabolic activities in pancreatic cancer.
    Bryant, Kirsten L.
    Hobbs, G. Aaron
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 21 - 22
  • [9] Identification of T-cell receptors targeting mutant KRAS in pancreatic cancer
    Bear, Adham S.
    Rech, Andrew J.
    Richman, Lee P.
    O'Hara, Mark H.
    Linette, Gerald P.
    Carreno, Beatriz M.
    Vonderheide, Robert H.
    CANCER RESEARCH, 2019, 79 (24)
  • [10] Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer.
    Ozkan-Dagliyan, Irem
    Goodwin, Craig M.
    Bryant, Kirsten L.
    George, Samuel D.
    Lucas, Kelly
    Gautam, Prson
    Wennerberg, Krister
    Cox, Adrienne D.
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 68 - 68